Diagnostyka stock

DIA · GPW · PLN

Compare Diagnostyka
zł 151.00Change from previous close: +1.48%Absolute change: +zł 2.20

Close · November 20, 2026

Price history

−14.40% over the period

1 year: from zł 176.40 (November 20, 2025) to zł 151.00 (November 20, 2026), −14.40%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026zł 151.00
October 30, 2026zł 148.40
September 30, 2026zł 160.70
August 31, 2026zł 168.90
July 31, 2026zł 166.60
June 30, 2026zł 173.70
May 29, 2026zł 177.90
April 30, 2026zł 152.00
March 31, 2026zł 171.40
February 27, 2026zł 188.65
January 30, 2026zł 189.75
December 30, 2025zł 171.00
November 28, 2025zł 170.55
November 20, 2025zł 176.40

At a glance

  • The company

    Polish medical laboratory providing diagnostic services including ultrasound, X-ray, CT scans, MRI, and specialized microbiology and molecular biology testing

  • Latest results

    Quarter to June 30, 2026 · EPS zł 1.70

TickerLandia's take on Diagnostyka

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowzł 144.10
52-wk highzł 208.00

−27.40% from the 52-week high

Analysts · 7 analysts

Average targetzł 191.39+26.75% vs. price

Buy 4 · Hold 3 · Sell 0

TickerLandia Fingerprint: Diagnostyka

Compared with similar companies: weak momentum, high earnings stability, and low financial strength.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Diagnostyka is cheaper than similar companies

Diagnostyka's P/E (trailing 12 months): 20.2, −29% against the median of a group of 10 similar companies (28.6).

Compared with 10 similar companies

Diagnostyka's metrics compared with similar companies
MetricDiagnostykaPosition in the groupBand
P/E (trailing 12 months)20.2Low
Forward P/E15.6Low
Operating margin14.9%Middle
ROE55.4%High
Debt/equity2.32High

Grey band: the middle half of the group; tick: the median; dot: Diagnostyka. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

zł 683.02M

Latest quarter · Q2 2026

Net income

zł 57.39M

Latest quarter · Q2 2026

Quarterly net margin

8.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
zł 5.14B
P/E
20.2
EPS
zł 7.55
Volume
38.33K
Daily trading
€1.11M
Dividend yield
2.91%
Last ex-dividend on June 1, 2026

How Diagnostyka is changing

All results
  • Revenue grew 18.9% a year on average over the last 3 years

  • Operating margin fell from 17.6% to 15.9%

  • Profits turn into cash: free cash flow equal to 148% of net income

Returns

Diagnostyka returns with dividends

zł 1,000 invested in Diagnostyka 1 year ago, on November 20, 2025, would be worth zł 878 today with dividends reinvested: −12.22% in total, −12.22% per year. On price alone it would be zł 856 (−14.40%).

PeriodDiagnostykazł 1,000 becomes
1 month−2.58%zł 974
6 months−6.62%zł 934
Year to date−11.70%zł 883
1 year−12.22%zł 878

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Diagnostyka: technical analysis

Diagnostyka is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 30.3% below its all-time closing high (zł 216.70, September 12, 2025).

Trend
Downward
RSI (14 sessions)
45
Between 30 and 70
vs 200-session average
−9.46%

Support and resistance

Price areas where Diagnostyka has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistancezł 160.00+5.96%2 touches, last on October 13, 2026
  2. Resistancezł 157.82+4.52%2 touches, last on October 1, 2026
  3. Resistancezł 155.07+2.69%3 touches, last on October 9, 2026
  4. Last pricezł 151.00
  5. No support below: the price is near the lows of the year

Volatility and risk

Volatility (60 sessions, annualised)
22.4%
Largest fall in the last year
−27.89%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Diagnostyka and its competitors

Based in Kraków, Diagnostyka S.A. has been active since 1998 as a medical laboratory serving clients across Poland. Its offer combines imaging procedures, namely magnetic resonance imaging, computed tomography, X-ray and ultrasound, with specialised laboratory research in microbiology, autoimmunity, toxicology and molecular biology. The company also carries out human genome research, histopathological and cytological examinations, immunohistochemical tests and cytogenetic tests. Its customers are individual clients as well as public and private entities. Its activities are concentrated in Poland.

Headquarters
Kraków, Poland
Employees
8,645
Founded
1998
Chief executive
Jakub Swadzba
Diagnostyka and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
DiagnostykaDIA$1.27B14.9%20.2−6.62%
DiaSorinDIA$4.21B22.3%28.6+14.88%
QiagenQIA$10.23B26.7%28.5+50.69%
bioMérieuxBIM$11.82B16.0%23.4+25.67%
Eurofins ScientificERF$16.03B14.1%29.6+37.31%
Lonza GroupLONN$54.2B23.5%43.2+32.22%

Same industry or related industries, similar size. Compare Diagnostyka with its competitors · Full profile